These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4008988)
21. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic. Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307 [TBL] [Abstract][Full Text] [Related]
22. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses. Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208 [TBL] [Abstract][Full Text] [Related]
23. Study of the immunogenicity of trivalent inactivated whole-virion influenza vaccine in human volunteers. Moffat MA; Pennington TH; Robertson AM; van Voorthuizen WF J Biol Stand; 1982 Apr; 10(2):83-90. PubMed ID: 7096364 [No Abstract] [Full Text] [Related]
24. [Testing of influenza virus vaccines--an international comparison]. Klett G; Stäber H; Willkommen H Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931 [No Abstract] [Full Text] [Related]
25. [The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics]. Podcherniaeva RIa; Döhner L; Medvedeva TE; Aleksandrova GI Vopr Virusol; 1991; 36(2):100-2. PubMed ID: 1882517 [TBL] [Abstract][Full Text] [Related]
26. Studies in man with cold-recombinant influenza virus (H1N1) live vaccines. Reeve P; Gerendas B; Moritz A; Liehl E; Kunz C; Hofmann H; Maassab HF J Med Virol; 1980; 6(1):75-83. PubMed ID: 7014783 [TBL] [Abstract][Full Text] [Related]
27. Infectivity and antigenicity of live avian-human influenza A reassortant virus: comparison of intranasal and aerosol routes in squirrel monkeys. Snyder MH; Stephenson EH; Young H; York CG; Tierney EL; London WT; Chanock RM; Murphy BR J Infect Dis; 1986 Oct; 154(4):709-11. PubMed ID: 3745978 [No Abstract] [Full Text] [Related]
28. Production of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus. Yamada A; Okuno Y; Takahashi M; Nakajima K Biken J; 1980 Mar; 23(1):25-32. PubMed ID: 7437002 [TBL] [Abstract][Full Text] [Related]
29. Influenza A (H3N2) component of recommended vaccine induces antibody to current virus. Zuckerman M; Oxford J; Wood J; Taylor J Lancet; 1990 Jan; 335(8682):179-80. PubMed ID: 1967480 [No Abstract] [Full Text] [Related]
30. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination]. Rudenko LG; Shvartsman IaS; Ispolatova AV; Grigor'eva EP; Drinevskiĭ VP Vopr Virusol; 1989; 34(1):29-34. PubMed ID: 2728404 [TBL] [Abstract][Full Text] [Related]
31. Antineuraminidase antibody response to vaccination of chickens with intact virus and different submit preparations of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2). Drescher J; Desselberger U Arch Virol; 1980; 64(3):235-46. PubMed ID: 6157375 [TBL] [Abstract][Full Text] [Related]
32. Antigenic variation of recent influenza A(H3N2) viruses. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(3):38-40, 46-7. PubMed ID: 3122010 [No Abstract] [Full Text] [Related]
33. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Cox NJ; Maassab HF; Kendal AP Virology; 1979 Aug; 97(1):190-4. PubMed ID: 473592 [No Abstract] [Full Text] [Related]
34. Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine. Clements ML; Tierney EL; Murphy BR J Clin Microbiol; 1985 Jun; 21(6):997-9. PubMed ID: 4008629 [TBL] [Abstract][Full Text] [Related]
35. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season. Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097 [TBL] [Abstract][Full Text] [Related]
36. Leads from the MMWR. Antigenic variation of recent influenza A(H3N2) viruses. JAMA; 1988 Feb; 259(7):972, 975. PubMed ID: 3339810 [No Abstract] [Full Text] [Related]
37. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. Clements ML; Snyder MH; Sears SD; Maassab HF; Murphy BR J Infect Dis; 1990 May; 161(5):869-77. PubMed ID: 2324538 [TBL] [Abstract][Full Text] [Related]
38. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300 [TBL] [Abstract][Full Text] [Related]
39. Influenza vaccines. Tyrrell DA Philos Trans R Soc Lond B Biol Sci; 1980 Feb; 288(1029):449-60. PubMed ID: 6103563 [TBL] [Abstract][Full Text] [Related]
40. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]